CHRISTINE SLOCUM: Open Payments
NPI 1063573053 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 35 payments from 11 companies in 2025. Trend: 2023 $621 · 2024 $27 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $253 |
| Corium, LLC | 4 | $110 |
| Alkermes, Inc. | 3 | $84 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: VRAYLAR, Azstarys, ARISTADA, Auvelity, INGREZZA, SPRAVATO, COBENFY, Qelbree.
Industry payments across NY — which companies pay providers there.
